1 Min Read
Aug 22 (Reuters) - Cellectar Biosciences Inc
* Cellectar Biosciences announces significant PDC platform advancement; demonstrates potential to improve therapeutic window Source text for Eikon: Further company coverage: (Reporting by Taenaz Shakir)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.